News

Filter

Current filters:

Evotec

1 to 9 of 13 results

Evotec and Sanofi negotiate 250 million euro strategic collaboration

Evotec and Sanofi negotiate 250 million euro strategic collaboration

03-12-2014

German biotech company Evotec has entered into exclusive negotiations with French drug major Sanofi on…

EvotecFranceGermanyPharmaceuticalResearchSanofi

Convergence Pharma and Evotec collaborate on chronic pain drugs

Convergence Pharma and Evotec collaborate on chronic pain drugs

31-03-2014

Independent UK biotech firm Convergence Pharmaceuticals has entered into a research alliance with Germany’s…

BiotechnologyConvergence PharmaceuticalsEvotecNeurologicalResearch

Evotec acquires Cell Culture Service GmbH; expands deal with AstraZeneca

07-01-2013

German biotech firm Evotec (EVT: TecDAX) has acquired all the shares in Cell Culture Service GmbH (CCS),…

AstraZenecaBiotechnologyCell Culture Service GmbHDiabetesEvotecLicensingMedImmuneMergers & AcquisitionsPharmaceutical

Evotec in up to $175 million NMDA antagonist license deal with Janssen

19-12-2012

Germany's Evotec (EVT: TecDAX) has entered into a license agreement with Janssen Pharmaceuticals, a subsidiary…

EvotecJanssenJohnson & JohnsonLicensingNeurologicalPharmaceutical

Bayer inks up to 592 million-euro endometriosis deal with Evotec

02-10-2012

Drug major Bayer (BAYN: DE) and fellow German company Evotec (EVT: TecDAX) have entered into a five-year,…

BayerEvotecLicensingPharmaceuticalWomen's Health

Janssen in-licenses insulin-producing beta cells from Evotec

10-07-2012

German biotech firm Evotec AG (EVT: TecDAX) has licensed to Janssen Pharmaceuticals, a unit of US health…

BiotechnologyDiabetesEvotecJanssenJohnson & JohnsonLicensing

Evotec out-licenses EVT 401 in China to Conba Pharma

03-05-2012

Hamburg, Germany-based Evotec AG (EVT: TecDAX) has granted a development and marketing license on EVT…

Asia-PacificConba PharmaceuticalsEvotecInflammatory diseasesLicensingPharmaceutical

1 to 9 of 13 results

Back to top